Interventions for Tuberculosis Control and Elimination 2002

456. Mitchison DA. The action of antituberculosis drugs in short-course chemotherapy.
Tubercle 1985; 66: 219-25.
457. Donald PR, Sirgel FA, Botha FJ, Seifart HI, Parkin DP, Vandenplas ML, Van
de Wal BW, Maritz JS, Mitchison DA. The early bactericidal activity of isoniazid
related to its dose size in pulmonary tuberculosis.
Med 1997; 156: 895-900.
Am J Respir Crit Care
458. Kamat SR, Dawson JJY, Devadatta S, Fox W, Janardhanam B, Radhakrishna S,
Ramakrishnan CV, Somasundaram PR, Stott H, Velu S. A controlled study of
the influence of segregation of tuberculous patients for one year on the attack
rate of tuberculosis in a 5-year period of close family contacts in south India.
Bull World Health Organ 1966; 34: 517-32.
459. Rouillon A, Perdrizet S, Parrot R. Transmission of tubercle bacilli: the effects
of chemotherapy. Tubercle 1976; 57: 275-99.
460. Grosset J. New microbial aspects of the treatment of tuberculosis. In: Luvarà A,
Ed. Rifampicin. TB today: from prevention of resistance to prevention of relapse.
A symposium held at the Forlanini Insititute, Rome June 19, 1997. Amsterdam:
Excerpta Medica, 1977; 1-11.
461. Fox W.
177-90.
The current status of short-course chemotherapy. Tubercle 1979; 60:
462. Dickinson JM, Mitchison DA. Experimental models to explain the high sterilizing
activity of rifampin in the chemotherapy of tuberculosis.
Dis 1981; 123: 367-71.
Am Rev Respir
463. Mitchison DA. Treatment of tuberculosis. The Mitchell Lecture 1979. J Roy
Coll Phys London 1980; 14: 91-9.
464. Mitchison DA. How drug resistance emerges as a result of poor compliance during
short course chemotherapy of tuberculosis.
10-5.
Int J Tuberc Lung Dis 1998; 2:
465. British Medical Research Council. Streptomycin treatment of pulmonary tuberculosis.
A Medical Research Council investigation. BMJ 1948; 2: 769-83.
466. Canetti G. The J. Burns Amberson lecture. Present aspects of bacterial resistance
in tuberculosis. Am Rev Respir Dis 1965; 92: 687-703.
467. Pyle MM. Relative numbers of resistant tubercle bacilli in sputa of patients
before and during treatment with streptomycin.
22: 465-73.
Proc Staff Meet Mayo Clin 1947;
468. Crofton J, Mitchison DA.
BMJ 1948; 2: 1009-15.
Streptomycin resistance in pulmonary tuberculosis.
469. Mitchison DA. Sensitivity testing. In: Heaf F, Rusby NL, Eds. Recent advances
in respiratory tuberculosis. London: J & A Churchill Ltd, 1968; 160-182.
470. Orme IM. The latent tuberculosis bacillus (I’ll let you know if I ever see one).
(Counterpoint). Int J Tuberc Lung Dis 2001; 5: 589-93.
199